Oppenheimer raised its price target on CME Group Inc. (NASDAQ:CME) to $300 from $282, maintaining an Outperform rating, as ...

Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...

With 12 analysts recently revising earnings estimates upward and a consensus target price suggesting current fair valuation, CME Group continues to demonstrate strong market leadership.

Interest-rate futures showed chances of three or more cuts this year at around 35% Thursday, up from about 29% Wednesday and 22% at the end of last week, according to CME Group. In focus this morning ...

Currently, the analyst consensus on CME Group is a Moderate Buy with an average price target of $275.86. Based on CME Group’s latest earnings release for the quarter ending March 31, the company ...

CME Group's strong performance and market-agnostic revenues support its resilience. Find out why CME stock is a Hold.

CME Group offers strong cash flow, market dominance, and a resilient business model. Click here to see why CME stock is a Buy ...